維爾利(300190.SZ):聯合體預中標馬橋再生資源化利用PPP項目 項目投資規模5.85億元
格隆匯3月31日丨維爾利(300190.SZ)公佈,公司於近期參與了馬橋再生資源化利用PPP項目的投標,根據中國政府採購網於2020年3月30日發佈的《上海市閔行區綠化和市容管理局馬橋再生資源化利用項目PPP招標預中標結果公示》,公司(聯合體牽頭人)與國投生態環境投資發展有限公司(聯合體成員)、上海建工七建集團有限公司(聯合體成員)組成的聯合體為該項目的入圍供應商。該項目PPP合作範圍投資規模約人民幣5.85億元,政府資源化利用處理服務費單價報價66.5元/噸。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.